Specialties

Meet the Expert: Prof. C. Ola Landgren discusses MRD as a key endpoint in haematological cancer trials

Expert

Prof. C. Ola Landgren, University of Miami, FL, USA

Conference

EHA 2024

10 July 2024 16:53

New atrial fibrillation associated with a high risk of major cardiovascular outcomes

Presented By

Dr Alexander Benz, Population Health Research Institute, Canada

Trial

COMPASS

Conference

EHRA 2024

Type

News article

29 April 2024 15:10

Treatment choices beyond immunotherapy in relapsed/refractory multiple myeloma

Presented By

Dr Rakesh Popat, University College London Hospitals, UK

Conference

EMN 2024

23 April 2024 11:42

22 April 2024 15:31

Dit is een proefdocument

Author(s)

Willers et al.

27 November 2023 19:22

Author(s)

Bandyopadhyay et al.

20 November 2023 13:45

Author(s)

et al.

20 November 2023 12:52

Author(s)

et al.

19 November 2023 15:30

Author(s)

et al.

19 November 2023 15:29

Author(s)

et al.

18 November 2023 16:53

Comorbidity in adult psoriasis

Author(s)

Näslund-Koch et al.

13 November 2023 17:38

Comorbidity in adult psoriasis

Author(s)

Näslund-Koch et al.

13 November 2023 17:33

Comorbidity in adult psoriasis

Author(s)

Näslund-Koch et al.

13 November 2023 16:47

PSMA PET is a predictive biomarker in mCRPC progressing after docetaxel

Presented By

Prof. Michael Hofman, Peter MacCallum Cancer Centre, Australia

Trial

Phase 2, TheraP

Conference

ASCO GU 2022

Type

Peer-reviewed article

8 April 2022 11:23

GLOW: Ibrutinib plus venetoclax showed superior efficacy as first-line treatment of CLL

Presented By

Prof. Arnon Kater, Amsterdam University Medical Centre, the Netherlands

Trial

Phase 3, GLOW

Conference

EHA 2021

16 June 2021 11:18

The discovery and diagnosis of COVID-19 vaccine-induced immune thrombotic thrombocytopenia

Presented By

Prof. Sabine Eichinger, Medical University Hospital of Vienna, Austria

Conference

EHA 2021

16 June 2021 11:06

Fixed 12 cycles and MRD-guided venetoclax consolidation is highly effective in CLL

Presented By

Dr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands

Trial

Phase 2, HOVON 139/GiVe

Conference

EHA 2021

16 June 2021 10:52

ELEVATE-RR: Acalabrutinib demonstrates similar efficacy and better safety compared with ibrutinib

Presented By

Prof. Peter Hillmen, St James’s University Hospital, UK

Trial

Phase 3, ELEVATE-RR

Conference

EHA 2021

16 June 2021 09:50

Naratuximab emtansine plus rituximab is safe and effective in diffuse large B-cell lymphoma

Presented By

Dr Moshe Yair Levy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, TX, US

Trial

Phase 2

Conference

EHA 2021

16 June 2021 09:25

Finerenone may reduce risk of AF onset in patients with CKD and diabetes

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

FIDELIO-DKD

Conference

ACC 2021

19 May 2021 10:32

Evinacumab lowers triglyceride levels in severe hypertriglyceridaemia

Presented By

Prof. Robert Rosenson, Icahn School of Medicine, USA

Trial

Phase 2

Conference

ACC 2021

19 May 2021 10:27

Pulmonary artery thrombectomy a safe alternative to thrombolytics

Presented By

Dr Jason Cottrell, Ohio Health Riverside Methodist Hospital, USA

Conference

ACC 2021

19 May 2021 10:25

Atorvastatin does not reduce mortality in COVID-19

Presented By

Dr Behnood Bikdeli, Brigham and Women’s Hospital, USA

Trial

INSPIRATION

Conference

ACC 2021

19 May 2021 10:23

Therapeutic anticoagulation inferior to prophylactic anticoagulation in COVID-19

Presented By

Prof. Renato Lopes, Duke University, USA

Trial

ACTION

Conference

ACC 2021

19 May 2021 10:22

Moderate hypothermia not superior to mild hypothermia following out-of-hospital heart attack

Presented By

Dr Michel Le May, University of Ottawa, USA

Trial

CAPITAL CHILL

Conference

ACC 2021

19 May 2021 10:19

TALOS-AMI: Superior outcomes clopidogrel over ticagrelor following 1-month DAPT

Presented By

Prof. Kiyuk Chang, Seoul St. Mary’s Hospital, South Korea

Trial

TALOS-AMI

Conference

ACC 2021

18 May 2021 11:51

Dapagliflozin fails to show a significant protective effect in COVID-19

Presented By

Prof. Mikhail Kosiborod, Saint Luke’s Mid America Heart Institute, USA

Trial

DARE-19

Conference

ACC 2021

18 May 2021 11:49

Rivaroxaban reduces total ischaemic events after peripheral artery revascularisation

Presented By

Dr Rupert Bauersachs, Klinikum Darmstadt, Germany

Trial

VOYAGER PAD

Conference

ACC 2021

18 May 2021 11:47

Similar outcomes fractional flow reserve and angiography-guided revascularisation

Presented By

Prof. Etienne Puymirat, University of Paris, France

Trial

FLOWER-MI

Conference

ACC 2021

18 May 2021 11:44

Clopidogrel superior to aspirin as monotherapy after DAPT in HOST-EXAM trial

Presented By

Prof. Hyo-Soo Kim, Seoul National University Hospital, South Korea

Trial

HOST-EXAM

Conference

ACC 2021

18 May 2021 11:38

Older adults with heart failure benefit from rehabilitation programme

Presented By

Dr Dalane Kitzman, Wake Forest School of Medicine, USA

Trial

REHAB-HF

Conference

ACC 2021

18 May 2021 11:36

Low-dose as effective as regular strength aspirin in preventing CV events

Presented By

Prof. William S. Jones, Duke Clinical Research Institute, USA

Trial

ADAPTABLE

Conference

ACC 2021

17 May 2021 10:32

Apixaban outcomes comparable with current standard of care following TAVR

Presented By

Dr Jean-Phillippe Collet, Sorbonne Université, France

Trial

Phase 3, ATLANTIS

Conference

ACC 2021

17 May 2021 10:28

Sacubitril/valsartan does not lower risk of heart failure versus ramipril

Presented By

Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA

Trial

Phase 3, PARADISE-MI

Conference

ACC 2021

17 May 2021 10:25

Mavacamten emerges as a new therapy for hypertrophic cardiomyopathy

Presented By

Prof. John Spertus, St. Luke’s Mid America Heart Institute, USA

Trial

Phase 3, EXPLORER-HCM

17 May 2021 10:24

Men and women benefit equally from early aspirin withdrawal following PCI

Presented By

Dr Birgit Vogel, Icahn School of Medicine, USA

Trial

TWILIGHT

Conference

ACC 2021

17 May 2021 10:22

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By

Dr Matthew Price, Scripps Clinic, California, USA

Journal

LAAO registry

Conference

ACC 2021

17 May 2021 10:20

DOACs and bleeding: the role of antidotes

Presented By

Dr Kaveshree Govender, Milpark Hospital, South Africa

Conference

EHRA 2021

25 April 2021 21:29

Added but limited value of ECG-based mortality prediction in COVID-19 patients using machine learning

Presented By

Dr Hidde Bleijendaal, Amsterdam University Medical Center, the Netherlands

Conference

EHRA 2021

25 April 2021 21:28

EHRA practical guide on cardiac imaging in electrophysiology

Presented By

Prof. Thomas Deneke, Heart Centre Bad Neustadt, Germany

Conference

EHRA 2021

25 April 2021 08:55

Subcutaneous implantable cardioverter-defibrillator maintains efficacy over 5 years

Presented By

Prof. Pier Lambiase, University College London, UK

Trial

EFFORTLESS S-ICD

Conference

EHRA 2021

25 April 2021 08:54

STROKESTOP: Benefits of systematic screening for atrial fibrillation

Presented By

Dr Emma Svennberg, Karolinska Institute, Danderyd Hospital, Sweden

Trial

STROKESTOP

Conference

EHRA 2021

24 April 2021 21:30

Components of AF management and early rhythm-control therapy in EAST-AFNET 4

Presented By

Dr Andreas Metzner, University Heart & Vascular Center Hamburg, Germany

Trial

Phase 4, EAST-AFNET 4

Conference

EHRA 2021

24 April 2021 21:30

RACE 3: early benefits targeted therapy in AF and HF diminished at 5-year follow-up

Presented By

Prof. Michiel Rienstra, University Medical Center Groningen, the Netherlands

Trial

RACE 3

Conference

EHRA 2021

24 April 2021 21:29

Personalised pulmonary vein isolation procedure feasible and effective

Presented By

Dr Cheryl Terés, Teknon Medical Centre, Spain

Trial

Ablate-by-LAW

Conference

EHRA 2021

24 April 2021 21:28

Young-onset atrial fibrillation: predictors and clinical profile

Presented By

Dr Amitai Segev, Sheba Medical Centre, Israel

Conference

EHAR 2021

24 April 2021 21:27

Vitamin D supplement improves asthma control in adults with deficiency

Journal

Thorax

23 November 2020 17:45

Oasis

11 November 2020 10:53

New hope for epidermolysis bullosa patients

Presented By

Prof. Dedee F. Murrell, St George Hospital, University of New South Wales, Australia

Conference

EADV 2020

3 November 2020 12:51

Oral JAK 1 inhibitor leads to fast itch relieve and remarkable skin clearance in AD

Presented By

Prof. Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, USA

Conference

EADV 2020

3 November 2020 12:48

Efficacious non-steroidal topical for psoriasis

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Conference

EADV 2020

3 November 2020 12:45

Zinc oxide coated socks against foot odour

Presented By

Dr Punyawee Ongsri, Siriraj Piyamaharajkarun Hospital, Mahidol University, Thailand

Conference

EADV 2020

3 November 2020 12:43

Topical TYK2/JAK 1 inhibitor effective and tolerable in mild-to-moderate AD

Presented By

Prof. Megan Landis, University of Louisville School of Medicine, USA

Conference

EADV 2020

3 November 2020 12:41

Secukinumab: a new management option for paediatric severe psoriasis

Presented By

Prof. Christine Bodemer, Necker–Enfants Malades Hospital, France

Conference

EADV 2020

2 November 2020 10:41

Sleep quality of partners of psoriasis patients

Presented By

Dr Giovanni Damiani , University of Milan, Italy

Conference

EADV 2020

2 November 2020 10:38

Oral prevention of skin cancer

Presented By

Dr Yolanda Gilaberte Calzada, Miguel Servet University Hospital, Spain

Conference

EADV 2020

2 November 2020 10:36

Low early PASI response could predict favourable outcomes for psoriasis patients on biologics

Presented By

Dr Nikolai Dyrberg, University of Copenhagen, Denmark

Conference

EADV 2020

2 November 2020 10:34

Discontinuation of omalizumab during COVID-19 pandemic associated with poor outcomes for chronic spontaneous urticaria

Presented By

Dr Ailye Sevdem Gulcan, Bezmialem Vakif University, Turkey

Conference

EADV 2020

2 November 2020 10:33

Impact of personal protective equipment on acne vulgaris and rosacea

Presented By

Dr Giovanni Damiani, University of Milan, Italy

Conference

EADV 2020

2 November 2020 10:31

Real-world data on brodalumab affirm efficacy and fast onset of action

Presented By

Dr Ralph Von Kiedrowski

Conference

EADV 2020

30 October 2020 14:59

Biologic psoriasis treatment and COVID-19 risk: still a matter of debate

Presented By

Dr Anne-Claire Fougerousse; Dr Giovanni Damiani

Conference

EADV 2020

30 October 2020 14:57

Hidradenitis suppurativa: beware of psychiatric comorbidities and suicidal ideation

Presented By

Dr Kevin Phan, Liverpool Hospital, Sydney, Australia

Conference

EADV 2020

30 October 2020 14:55

IL-23p19 class antibody efficacious in psoriasis management

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Conference

EADV 2020

30 October 2020 14:52

Topical pan-JAK inhibitor achieved efficacy and fast onset in chronic hand eczema

Presented By

Prof. Margitta Worm, Charité Universitätsmedizin Berlin, Germany

Conference

EADV 2020

30 October 2020 14:49

JAK1 inhibition successful in hidradenitis suppurativa

Presented By

Dr Afsaneh Alavi, Mayo Cinic, USA

Conference

EADV 2020

30 October 2020 14:47

EAU20 Virtual

13 July 2020 10:09

Rivaroxaban monotherapy non-inferior to combination therapy in AF and stable CAD patients

Expert

Dr Satoshi Yasuda, National Cerebral and Cardiovascular Centre, Japan

Trial

AFIRE

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 12:29